ARTV
Artiva Biotherapeutics, Inc.
7.00$
-6.7%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| – | 100.0% | 100.0% | 100.0% | 100.0% | – | |
| – | 100.0% | 100.0% | 100.0% | 100.0% | – | |
| – | 2,118.4% | 892.0% | 150.0% | 20,051.0% | – | |
| – | 642.6% | 421.3% | 41.5% | 6,854.6% | – | |
| – | 2,760.9% | 1,313.3% | 191.6% | 26,905.6% | – | |
| – | -2,660.9% | -1,213.3% | -91.6% | -26,805.6% | – | |
| – | 0.0% | – | – | – | – | |
| – | -3,587.7% | -1,183.0% | -82.5% | -23,304.0% | – | |
| – | -926.7% | 1.1% | 0.2% | – | – | |
| – | -3,587.7% | -1,184.1% | -82.7% | -23,304.0% | – | |
| – | -3,575.3% | -1,159.5% | -75.7% | -22,335.5% | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.